title: New drug update: 2007.
abstract: A unique rating system compares five new drugs with existing therapies and evaluates the uses and most important properties of each new agent. Advantages, disadvantages, and other important information regarding the new drug are considered and identified, including their use in the elderly.
authors.affiliation: Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, Pennsylvania, USA.
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Hussar
mesh_terms: D000368:Aged; D000577:Amides / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D017277:Drug Approval; D005650:Fumarates / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D007555:Isoxazoles / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D008268:Macular Degeneration / Q000188:drug therapy; D000068882:Paliperidone Palmitate; D011719:Pyrazines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D011743:Pyrimidines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D000069579:Ranibizumab; D000068900:Sitagliptin Phosphate; D013764:Tetrahydronaphthalenes / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D013876:Thiophenes / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D014230:Triazoles / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D014481:United States
chemical_list: D000577:Amides; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000959:Antihypertensive Agents; D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D005650:Fumarates; D007004:Hypoglycemic Agents; D007555:Isoxazoles; D011719:Pyrazines; D011743:Pyrimidines; D013764:Tetrahydronaphthalenes; D013876:Thiophenes; D014230:Triazoles; C446481:aliskiren; C047508:rotigotine; D000068882:Paliperidone Palmitate; D000068900:Sitagliptin Phosphate; D000069579:Ranibizumab